US Stock MarketDetailed Quotes

ICCM Icecure Medical

Watchlist

0.786
+0.009+1.19%

Close Nov 26 16:00 ET

0.790
+0.004+0.45%

Post 20:02 ET

43.65MMarket Cap-2808P/E (TTM)

Icecure Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

40.49%-2.36M

2.89%-2.85M

12.39%-12.52M

35.95%-2.64M

10.55%-2.97M

-4.91%-3.97M

4.02%-2.94M

-13.38%-14.29M

29.96%-4.13M

-5.37%-3.32M

Net income from continuing operations

20.78%-3.08M

4.22%-3.61M

13.70%-14.65M

24.22%-3M

1.43%-4M

13.98%-3.89M

15.27%-3.77M

-71.58%-16.98M

-25.06%-3.95M

-40.51%-4.06M

Operating gains losses

-60.00%36K

437.50%43K

-106.96%-25K

-93.22%-228K

223.53%105K

-82.00%90K

-87.10%8K

7,080.00%359K

-71.01%-118K

-269.57%-85K

Depreciation and amortization

3.80%82K

7.59%85K

30.24%323K

12.16%83K

17.14%82K

51.92%79K

95.28%248K

80.49%74K

94.44%70K

Change In working capital

300.45%443K

-1.03%384K

144.39%523K

129.97%193K

-43.01%163K

11.95%-221K

-52.86%388K

106.78%214K

76.73%-644K

182.90%286K

-Change in receivables

-772.00%-168K

16.92%-54K

-106.61%-25K

-95.76%5K

183.33%10K

-90.46%25K

-750.00%-65K

204.42%378K

131.98%118K

-271.43%-12K

-Change in inventory

-19.77%142K

330.99%164K

164.52%582K

333.33%371K

323.40%105K

154.13%177K

80.76%-71K

-1.23%-902K

12.15%-159K

84.79%-47K

-Change in prepaid assets

-57.40%118K

-86.10%52K

-52.76%496K

125.04%161K

-177.83%-316K

-50.45%277K

-48.63%374K

151.72%1.05M

64.20%-643K

409.92%406K

-Change in payables and accrued expense

212.12%37K

637.93%156K

-26.95%-212K

-659.82%-627K

242.39%477K

-112.36%-33K

86.26%-29K

-170.76%-167K

166.67%112K

-1,057.14%-335K

-Change in other current assets

328.57%60K

56.25%75K

-25.71%182K

-21.95%64K

-17.65%56K

-78.79%14K

65.52%48K

140.36%245K

-29.31%82K

109.16%68K

-Change in other current liabilities

137.30%254K

-106.87%-9K

-28.21%-500K

242.21%219K

-182.04%-169K

36.83%-681K

-79.40%131K

-178.63%-390K

73.45%-154K

-74.09%206K

Cash from discontinued investing activities

Operating cash flow

40.49%-2.36M

2.89%-2.85M

12.39%-12.52M

35.95%-2.64M

10.55%-2.97M

-4.91%-3.97M

4.02%-2.94M

-13.38%-14.29M

29.96%-4.13M

-5.37%-3.32M

Investing cash flow

Cash flow from continuing investing activities

-156.28%-843K

103.25%491K

19.98%-713K

440.27%9.06M

74.94%3.85M

132.38%1.5M

-10,400.00%-15.12M

-123.50%-891K

1,036.31%1.68M

2,139.81%2.2M

Net PPE purchase and sale

91.67%-6K

88.80%-28K

46.13%-480K

19.00%-81K

74.16%-77K

79.37%-72K

-73.61%-250K

-67.17%-891K

43.82%-100K

-175.93%-298K

Net investment purchase and sale

-153.31%-837K

103.56%529K

---529K

397.75%8.84M

57.18%3.93M

136.71%1.57M

---14.87M

--0

502.03%1.78M

--2.5M

Net other investing changes

--0

---10K

--296K

----

Cash from discontinued investing activities

Investing cash flow

-156.28%-843K

103.25%491K

19.98%-713K

440.27%9.06M

74.94%3.85M

132.38%1.5M

-10,400.00%-15.12M

-123.50%-891K

1,036.31%1.68M

2,139.81%2.2M

Financing cash flow

Cash flow from continuing financing activities

1.89M

2.84M

-99.39%83K

-99.50%68K

15K

-56.05%13.58M

-16.40%13.58M

Net common stock issuance

--1.89M

--2.84M

--0

----

--0

-55.57%13.58M

----

Proceeds from stock option exercised by employees

----

4,050.00%83K

6,700.00%68K

----

-99.41%2K

-99.70%1K

--0

Cash from discontinued financing activities

Financing cash flow

--1.89M

--2.84M

-99.39%83K

-99.50%68K

--15K

--0

-56.05%13.58M

-16.40%13.58M

--0

Net cash flow

Beginning cash position

96.03%10.97M

-55.48%10.53M

-7.66%23.66M

-69.24%3.83M

-77.49%3.03M

-74.98%5.59M

-7.66%23.66M

631.61%25.62M

-19.16%12.44M

-27.64%13.47M

Current changes in cash

46.79%-1.32M

102.64%476K

-718.87%-13.15M

-41.76%6.48M

180.65%900K

70.59%-2.47M

-463.58%-18.06M

-107.27%-1.61M

9.41%11.12M

65.67%-1.12M

Effect of exchange rate changes

102.22%2K

-437.50%-43K

107.02%25K

132.65%228K

-223.53%-105K

81.13%-90K

87.10%-8K

-927.91%-356K

42.03%98K

269.57%85K

End cash Position

218.44%9.65M

96.03%10.97M

-55.48%10.53M

-69.24%3.83M

-77.49%3.03M

-74.98%5.59M

-7.66%23.66M

-19.16%12.44M

Free cash flow

41.40%-2.37M

9.63%-2.88M

14.37%-13M

35.55%-2.73M

15.79%-3.05M

2.20%-4.04M

0.53%-3.19M

-15.57%-15.18M

30.37%-4.23M

-11.02%-3.62M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	40.49%-2.36M	2.89%-2.85M	12.39%-12.52M	35.95%-2.64M	10.55%-2.97M	-4.91%-3.97M	4.02%-2.94M	-13.38%-14.29M	29.96%-4.13M	-5.37%-3.32M
Net income from continuing operations	20.78%-3.08M	4.22%-3.61M	13.70%-14.65M	24.22%-3M	1.43%-4M	13.98%-3.89M	15.27%-3.77M	-71.58%-16.98M	-25.06%-3.95M	-40.51%-4.06M
Operating gains losses	-60.00%36K	437.50%43K	-106.96%-25K	-93.22%-228K	223.53%105K	-82.00%90K	-87.10%8K	7,080.00%359K	-71.01%-118K	-269.57%-85K
Depreciation and amortization	3.80%82K	7.59%85K	30.24%323K	12.16%83K	17.14%82K	51.92%79K	51.92%79K	95.28%248K	80.49%74K	94.44%70K
Change In working capital	300.45%443K	-1.03%384K	144.39%523K	129.97%193K	-43.01%163K	11.95%-221K	-52.86%388K	106.78%214K	76.73%-644K	182.90%286K
-Change in receivables	-772.00%-168K	16.92%-54K	-106.61%-25K	-95.76%5K	183.33%10K	-90.46%25K	-750.00%-65K	204.42%378K	131.98%118K	-271.43%-12K
-Change in inventory	-19.77%142K	330.99%164K	164.52%582K	333.33%371K	323.40%105K	154.13%177K	80.76%-71K	-1.23%-902K	12.15%-159K	84.79%-47K
-Change in prepaid assets	-57.40%118K	-86.10%52K	-52.76%496K	125.04%161K	-177.83%-316K	-50.45%277K	-48.63%374K	151.72%1.05M	64.20%-643K	409.92%406K
-Change in payables and accrued expense	212.12%37K	637.93%156K	-26.95%-212K	-659.82%-627K	242.39%477K	-112.36%-33K	86.26%-29K	-170.76%-167K	166.67%112K	-1,057.14%-335K
-Change in other current assets	328.57%60K	56.25%75K	-25.71%182K	-21.95%64K	-17.65%56K	-78.79%14K	65.52%48K	140.36%245K	-29.31%82K	109.16%68K
-Change in other current liabilities	137.30%254K	-106.87%-9K	-28.21%-500K	242.21%219K	-182.04%-169K	36.83%-681K	-79.40%131K	-178.63%-390K	73.45%-154K	-74.09%206K
Cash from discontinued investing activities
Operating cash flow	40.49%-2.36M	2.89%-2.85M	12.39%-12.52M	35.95%-2.64M	10.55%-2.97M	-4.91%-3.97M	4.02%-2.94M	-13.38%-14.29M	29.96%-4.13M	-5.37%-3.32M
Investing cash flow
Cash flow from continuing investing activities	-156.28%-843K	103.25%491K	19.98%-713K	440.27%9.06M	74.94%3.85M	132.38%1.5M	-10,400.00%-15.12M	-123.50%-891K	1,036.31%1.68M	2,139.81%2.2M
Net PPE purchase and sale	91.67%-6K	88.80%-28K	46.13%-480K	19.00%-81K	74.16%-77K	79.37%-72K	-73.61%-250K	-67.17%-891K	43.82%-100K	-175.93%-298K
Net investment purchase and sale	-153.31%-837K	103.56%529K	---529K	397.75%8.84M	57.18%3.93M	136.71%1.57M	---14.87M	--0	502.03%1.78M	--2.5M
Net other investing changes	--0	---10K	--296K	----	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-156.28%-843K	103.25%491K	19.98%-713K	440.27%9.06M	74.94%3.85M	132.38%1.5M	-10,400.00%-15.12M	-123.50%-891K	1,036.31%1.68M	2,139.81%2.2M
Financing cash flow
Cash flow from continuing financing activities	1.89M	2.84M	-99.39%83K	-99.50%68K	15K	0	0	-56.05%13.58M	-16.40%13.58M	0
Net common stock issuance	--1.89M	--2.84M	--0	----	----	--0	--0	-55.57%13.58M	----	----
Proceeds from stock option exercised by employees	----	----	4,050.00%83K	6,700.00%68K	----	----	----	-99.41%2K	-99.70%1K	--0
Cash from discontinued financing activities
Financing cash flow	--1.89M	--2.84M	-99.39%83K	-99.50%68K	--15K	--0	--0	-56.05%13.58M	-16.40%13.58M	--0
Net cash flow
Beginning cash position	96.03%10.97M	-55.48%10.53M	-7.66%23.66M	-69.24%3.83M	-77.49%3.03M	-74.98%5.59M	-7.66%23.66M	631.61%25.62M	-19.16%12.44M	-27.64%13.47M
Current changes in cash	46.79%-1.32M	102.64%476K	-718.87%-13.15M	-41.76%6.48M	180.65%900K	70.59%-2.47M	-463.58%-18.06M	-107.27%-1.61M	9.41%11.12M	65.67%-1.12M
Effect of exchange rate changes	102.22%2K	-437.50%-43K	107.02%25K	132.65%228K	-223.53%-105K	81.13%-90K	87.10%-8K	-927.91%-356K	42.03%98K	269.57%85K
End cash Position	218.44%9.65M	96.03%10.97M	-55.48%10.53M	-55.48%10.53M	-69.24%3.83M	-77.49%3.03M	-74.98%5.59M	-7.66%23.66M	-7.66%23.66M	-19.16%12.44M
Free cash flow	41.40%-2.37M	9.63%-2.88M	14.37%-13M	35.55%-2.73M	15.79%-3.05M	2.20%-4.04M	0.53%-3.19M	-15.57%-15.18M	30.37%-4.23M	-11.02%-3.62M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data